Epitomeemedical
2 known investors
Epitomee develops ingestible capsule-based therapies that deploy in specific regions of the stomach, duodenum, and small intestine to provide mechano-sensory stimulation, targeted drug delivery, and absorption management before dissolving and passing naturally. The company partners with pharmaceutical and industry companies to commercialize these therapeutic applications.